Myriad Genetics Patient Outcomes Study Shows RiskScore : vimarsana.com

Myriad’s MyRisk™ Hereditary Cancer test with RiskScore® provides a personalized breast cancer risk assessment for women of all ancestries...

Related Keywords

San Antonio , Texas , United States , Mychoice Cdx , Thomas Slavin , Matt Scalo , Megan Manzari , Bracanalysis Cdx , Allison Kurian , Genetics Inc , Exchange Commission , Fast Company , Stanford University , World Most Innovative Companies , Nasdaq , Antonio Breast Cancer , Myriad Genetics , Myrisk Hereditary Cancer , Chief Medical Officer , Most Innovative Companies , Myriad Myrisk , Health Illuminated , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Current Reports , Nasdaq Mygn , Yriad Genetics , Nc , Reast Cancer , Abcs ,